SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001655759-24-000083
Filing Date
2024-05-31
Accepted
2024-05-31 17:51:47
Documents
4
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1717192298.html 4  
1 FORM 4 wk-form4_1717192298.xml 4 5805
2 EX-24.1 section16-directorformxp.htm EX-24.1 5375
3 section16-directorformxp001.jpg GRAPHIC 289828
4 section16-directorformxp002.jpg GRAPHIC 36106
  Complete submission text file 0001655759-24-000083.txt   461929
Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Morrison Briggs (Reporting) CIK: 0001654430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38672 | Film No.: 241011268

Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Issuer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)